https://doi.org/10.1016/j.ophtha.2017.05.035
S
Sérgio Leal
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
51
Papers
1.5K
Citations
15
h-index
23
i10-index
Sérgio Leal is an academic researcher from Radboud University Nijmegen. The author has contributed to research in topics: Retinal Diseases and Treatments & Retinal Imaging and Analysis & Retinal and Optic Conditions. The author has an h-index of 15, co-authored 44 publications.
ORCID: 0000-0001-7870-0478Papers by this author
worksPrevalence of Age-Related Macular Degeneration in Europe
2017 · Ophthalmology · 474 citations
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
2024 · The Lancet · 179 citations
https://doi.org/10.1016/s0140-6736(24)00063-1
Relative ellipsoid zone reflectivity and its association with disease severity in age-related macular degeneration: a MACUSTAR study report
2022 · Scientific Reports · 21 citations
https://doi.org/10.1038/s41598-022-18875-5
Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
2020 · Advances in Therapy · 14 citations
https://doi.org/10.1007/s12325-020-01580-y
Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial
2020 · Advances in Therapy · 13 citations
https://doi.org/10.1007/s12325-020-01579-5
Heterogeneous Visual Function Deficits in Intermediate Age-Related Macular Degeneration: A MACUSTAR Report
2025 · Ophthalmology Science · 4 citations
https://doi.org/10.1016/j.xops.2025.100708
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat